Literature DB >> 2448225

Sheep MHC class II molecules. I. Immunochemical characterization.

N K Puri1, M D Gorrell, M R Brandon.   

Abstract

The physicochemical features, biosynthesis and glycosylation of sheep class II molecules were investigated using a panel of seven monoclonal antibodies. The class II molecules recognized by different monoclonal antibodies could be differentiated using SDS-PAGE. Two monoclonal antibodies, SBU.II 42-20 and 49-1, reacted with dissociated sheep class II molecules and recognized epitopes on class II alpha and beta polypeptides, respectively. The structure of the sheep class II heterodimer differed from that of mouse and man in that it was unstable in the presence of 1% SDS at 20 degrees and, following reduction, sheep beta polypeptides displayed a marked increase in MW, resulting in the apparent co-migration of reduced alpha and beta polypeptides on SDS-PAGE. This phenomenon was not seen using sheep class II molecules synthesized in the presence of tunicamycin. Pulse-chase analyses of biosynthetically labelled sheep class II molecules suggested the rapid association and glycosylation of sheep class II alpha and beta polypeptides during synthesis. Both alpha and beta polypeptides of sheep class II molecules carried N-linked oligosaccharides of MW 6,000 and 3,000, respectively. However, unlike human class II oligosaccharides, these were exclusively of the complex or sialylated type.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448225      PMCID: PMC1454162     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  The output of cells in lymph from the popliteal node of sheep.

Authors:  J G HALL; B MORRIS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1962-10

Review 2.  Structure, function, and genetics of human class II molecules.

Authors:  R C Giles; J D Capra
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  A mild procedure for separating polypeptide chains prior to immunoprecipitation and western blotting analysis.

Authors:  B B Cohen; M Moxley; D Crichton; D L Deane; C M Steel
Journal:  J Immunol Methods       Date:  1984-12-14       Impact factor: 2.303

5.  The extracellular region of light chains from human and murine MHC class II antigens consists of two domains.

Authors:  J F Kaufman; J L Strominger
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

Review 6.  HLA-DR antigens: structure, separation of subpopulations, gene cloning and function.

Authors:  D A Shackelford; J F Kaufman; A J Korman; J L Strominger
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

7.  Sheep lymphocyte antigens (OLA). II. Major histocompatibility complex class II molecules.

Authors:  N K Puri; C R Mackay; M R Brandon
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

8.  Structural characterization of murine Ia antigen N-linked oligosaccharides and localization of specific structures to two unique alpha-chain glycosylation sites.

Authors:  E P Cowan; R D Cummings; D R Lee; B D Schwartz; S E Cullen
Journal:  Mol Immunol       Date:  1985-02       Impact factor: 4.407

9.  Structural analysis of the oligosaccharides of DR1 and DQw1 molecules.

Authors:  S Iturbe; S Narasimhan; M Letarte
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis.

Authors:  D A Shackelford; J L Strominger
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  10 in total

1.  Leucocyte phenotypes in involuting and fully involuted mammary glandular tissues and secretions of sheep.

Authors:  L Tatarczuch; C Philip; R Bischof; C S Lee
Journal:  J Anat       Date:  2000-04       Impact factor: 2.610

2.  Quantitative analysis of intraepithelial large granular lymphocyte distribution and maternofetal cellular interactions in the synepitheliochorial placenta of the deer.

Authors:  C S Lee; F B Wooding; G Morgan
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

3.  Involution of the sheep mammary gland.

Authors:  L Tatarczuch; C Philip; C S Lee
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

4.  Characterization of monoclonal antibodies specific for alpha- and beta-chains of sheep MHC class II.

Authors:  B M Dutia; J Hopkins; M P Allington; R Bujdoso; I McConnell
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

5.  Identification of a unique lymphocyte subpopulation in the sheep uterus.

Authors:  C S Lee; K Gogolin-Ewens; M R Brandon
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

6.  Some characteristics of ovine lymphoid cells infected in vivo by Theileria hirci.

Authors:  P Hooshmand-Rad; U Magnusson; A Uggla
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

7.  Characterization of the lymphocytic alveolitis in visna-maedi virus-induced interstitial lung disease of sheep.

Authors:  G Cordier; F Guiguen; J L Cadoré; G Cozon; M F Jacquier; J F Mornex
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

8.  Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes.

Authors:  M D Gorrell; M R Brandon; D Sheffer; R J Adams; O Narayan
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Sheep MHC class II molecules. II. Identification and characterization of four distinct subsets of sheep MHC class II molecules.

Authors:  N K Puri; M R Brandon
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

10.  Lymphocyte phenotypes in the intestinal mucosa of sheep infected with Trichostrongylus colubriformis.

Authors:  M D Gorrell; G Willis; M R Brandon; A K Lascelles
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.